Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patients pDC deficit of early response to toll-like receptor 7 agonist stimulation.
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.
[Diagnosis and differential diagnosis of demyelinating optic neuropathy in multiple sclerosis.]
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study.
Docosahexaenoic Acid and Cognition throughout the Lifespan.
What's in the Literature?
Regenerative Medicines for Remyelination: From Aspiration to Reality.
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.
The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases.
Progressive multifocal leukoencephalopathy in multiple sclerosis.
The Promoter SNP, but not the Alternative Splicing SNP, is Linked to Multiple Sclerosis Among Jordanian Patients.
Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model.
Established and novel disease-modifying treatments in multiple sclerosis.
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe?
Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
Disease mechanisms in MS: Cell adhesion molecule MCAM on pathogenic T cells-a green light for CNS entry in multiple sclerosis.
Robot Therapy Tipping Point: Caveats for Post hoc Speculation.
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
[Differential diagnosis of optic neuritis (review].
Psychiatric morbidity in patients with transverse myelitis and stroke: A comparison.
Systematic review versus internet search: considerations about availability and reliability of medical information regarding pregnancy in women with multiple sclerosis.
Pages
« first
‹ previous
…
540
541
542
543
544
545
546
547
548
…
next ›
last »